Established Direct-to-Consumer Medical Diagnostic Testing Platform

Opportunity to acquire an established direct-to-consumer medical diagnostic testing platform operating in the Canadian market. The business enables consumers to order private diagnostic testing online, with fulfillment through established third-party laboratory infrastructure, without the cost or capital required to operate a laboratory.

The business is asset-light and highly scalable. Demand is generated primarily through customer retention and referrals, strong organic search authority, and an established email program, with no paid advertising, resulting in strong, stable gross margins.

The platform suits an acquirer looking to own or expand a Canadian direct-to-consumer diagnostics channel, whether by integrating it into existing healthcare, laboratory, or telehealth infrastructure or by running it as a standalone cash-generating asset. It operates across multiple Canadian provinces, with a near-term opportunity to expand into additional provinces. Further growth avenues include recurring subscription panels, broader test menus, and digital marketing.

The current owner is a corporate group divesting a non-core asset and will support an extended transition, either by integrating the platform into an acquirer's existing infrastructure or by providing managed back-end support during handover.

Consumer demand for self-directed, preventative health has surged, with the wellness and longevity movement leading more people to pay out of pocket for diagnostics they cannot easily access through the public system. Persistent access friction in the public system, long waits, and difficulty obtaining non-urgent testing create a steady pipeline of customers willing to pay for speed and convenience. The broader direct-to-consumer diagnostics market has expanded sharply in recent years, normalizing the idea of consumers ordering and managing their own testing.

Highlights:

Established direct-to-consumer platform in a growing Canadian healthcare niche

Asset-light, low-overhead model built on third-party laboratory infrastructure

Loyal customer base with a returning-customer rate above 40%

Organic search and email-driven demand, with no paid advertising

Strong, stable gross margins in a high-margin healthcare niche

Multi-province footprint

Near-term provincial expansion and subscription growth potential

Transition support is available from the current ownership

Established Direct-to-Consumer Medical Diagnostic Testing Platform

Location: Canada
Industry: Healthcare & Life Sciences
Listing ID: BA2026703

Opportunity to acquire an established direct-to-consumer medical diagnostic testing platform operating in the Canadian market. The business enables consumers to order private diagnostic testing online, with fulfillment through established third-party laboratory infrastructure, without the cost or capital required to operate a laboratory.

The business is asset-light and highly scalable. Demand is generated primarily through customer retention and referrals, strong organic search authority, and an established email program, with no paid advertising, resulting in strong, stable gross margins.

The platform suits an acquirer looking to own or expand a Canadian direct-to-consumer diagnostics channel, whether by integrating it into existing healthcare, laboratory, or telehealth infrastructure or by running it as a standalone cash-generating asset. It operates across multiple Canadian provinces, with a near-term opportunity to expand into additional provinces. Further growth avenues include recurring subscription panels, broader test menus, and digital marketing.

The current owner is a corporate group divesting a non-core asset and will support an extended transition, either by integrating the platform into an acquirer's existing infrastructure or by providing managed back-end support during handover.

Consumer demand for self-directed, preventative health has surged, with the wellness and longevity movement leading more people to pay out of pocket for diagnostics they cannot easily access through the public system. Persistent access friction in the public system, long waits, and difficulty obtaining non-urgent testing create a steady pipeline of customers willing to pay for speed and convenience. The broader direct-to-consumer diagnostics market has expanded sharply in recent years, normalizing the idea of consumers ordering and managing their own testing.

Highlights:

Established direct-to-consumer platform in a growing Canadian healthcare niche

Asset-light, low-overhead model built on third-party laboratory infrastructure

Loyal customer base with a returning-customer rate above 40%

Organic search and email-driven demand, with no paid advertising

Strong, stable gross margins in a high-margin healthcare niche

Multi-province footprint

Near-term provincial expansion and subscription growth potential

Transition support is available from the current ownership

EBITDA: $500,000
Sign Our NDA

SIGN NDA


Request More Information

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form